Skip to main content
NVCR logo
NVCR
(NASDAQ)
NovoCure Limited
$17.99-- (--)
Loading... - Market loading

NovoCure (NVCR) Stock Price & Financial Analysis

NovoCure Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.23 - $18.39
52-Week High$19.25
52-Week Low$9.82
Open$16.23
Volume2.25M
Average Volume (3M)1.77M
Market Cap1.84B
Shares Outstanding114.15M
Price to Sales (P/S)2.68
Price to Book (P/B)5.46
EV/EBITDA-14.35
Revenue (TTM)674.41M
Net Income (TTM)-173.05M
Free Cash Flow (TTM)-48.07M
EPS (TTM)$-1.54
Profit Margin-25.66%
Operating Margin-27.19%
Return on Equity (ROE)-52.32%
Debt to Equity0.59
50-Day MA$14.26
200-Day MA$13.07
52-Week Change-5.22%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NovoCure

What is the current stock price for NVCR?

As of the latest trading session, NVCR stock trades at $17.99. The 52-week range is $9.82–$19.25, with a day range of $16.23–$18.39.

What is the P/E ratio for NVCR?

The P/E ratio (Price-to-Earnings) for NVCR is shown in the Key Statistics section. This valuation metric helps compare NovoCure Limited to industry peers.

Does NVCR pay dividends?

NovoCure does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NVCR?

Based on 1 analyst, the consensus for NVCR is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NVCR?

NovoCure's market capitalization is $2.05B, classifying it as a mid-cap company..